SXQ-13731-47413
3 vaccinations
1 coded response
2 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 985 / WA
- Registered
- 2021-09-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-08
Dose 1 — Pfizer-BioNTech
-
2021-03-01
Dose 2 — Pfizer-BioNTech
-
2021-09-03
Registered in v-safe
- 2021-09-03
-
2022-01-27
Dose 3 — Pfizer-BioNTech
-
2022-03-01
Survey response — 12 months, dose 2MedDRA: Adverse reaction, Postpartum state — Feeling: Good · Be unable to do your normal daily activitiesFree text: I am post partum so normal conditions that go with that.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-08 | Pfizer-BioNTech | No |
| 2 | 2021-03-01 | Pfizer-BioNTech | No |
| 3 | 2022-01-27 | Pfizer-BioNTech | No |
Free text
Release 11 — 12 months, dose 2
Symptoms: I am post partum so normal conditions that go with that.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Adverse reaction | · | · | ✓ |
| SD | Postpartum state | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release